renal fascia

出典: meddic

腎筋膜

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/10/03 02:51:20」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

英文文献

  • Transperitoneal Robot-Assisted Partial Nephrectomy: A Comparison of Posterior and Anterior Renal Masses.
  • Harris KT, Ball MW, Gorin MA, Curtiss KM, Pierorazio PM, Allaf ME.Author information The James Buchanan Brady Urological Institute and Department of Urology, The Johns Hopkins School of Medicine , Baltimore, Maryland.AbstractAbstract Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior tumors, it is a less familiar approach to many urologists. In our institution, a TP approach is used for all patients undergoing RAPN. We compared demographics and perioperative outcomes of TP RAPN for posterior and anterior/lateral renal masses. Methods: Our institutional renal mass database was queried for patients with available preoperative imaging who underwent TP RAPN from 2007 to 2013. Posterior masses were accessed by opening the Gerota fascia and rotating the kidney anteromedially. Demographic and perioperative outcomes were compared for patients with posterior masses and anterior/lateral masses. Results: Overall, 260 TP RAPN were identified. Of these, 92 were for posterior tumors and 168 were for anterior and lateral tumors. Renal-cell carcinoma (RCC) was found in 77.3% of cases. Patient demographic and tumor characteristics were similar between groups. Among operative characteristics, warm ischemia time (17 vs 16.5, min P=0.70), operative time (160 vs 159 min, P=0.82), estimated blood loss (100 vs 100 mL, P=0.44), RCC positive surgical margins (1.4% vs 1.5%), and postoperative complications (19.6% vs 16.1%, P=1.0) were similar for posterior and anterior/lateral tumors, respectively. Conclusions: TP RAPN is a safe, effective treatment option for patients with posterior renal masses with no additional morbidity compared with anterior/lateral renal masses. RP PN remains an alternative treatment option.
  • Journal of endourology / Endourological Society.J Endourol.2014 Feb 14. [Epub ahead of print]
  • Abstract Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior
  • PMID 24422597
  • Cephalic arch stenosis in dialysis patients: review of clinical relevance, anatomy, current theories on etiology and management.
  • Sivananthan G, Menashe L, Halin NJ.Author information Tufts Medical Center, Boston, MA - USA.Abstract<sec id="st1"><title>ABSTRACT</title> <bold>Arteriovenous hemodialysis fistulas (AVFs) serve as a lifeline for many individuals with end-stage renal failure. A common cause of AVF failure is cephalic arch stenosis. Its high prevalence compounded with its resistance to treatment makes cephalic arch stenosis important to understand. Proposed etiologies include altered flow in a fistulized cephalic vein, external compression by fascia, the unique morphology of the cephalic arch, large number of valves in the cephalic outflow tract and biochemical changes that accompany renal failure. Management options are also in debate and include angioplasty, cutting balloon angioplasty, bare metal stents, stent grafts and surgical techniques including flow reduction with minimally invasive banding as well as more invasive venovenostomy with transposition surgeries for refractory cases. In this review, the evidence for the clinical relevance of cephalic arch stenosis, its etiology and management are summarized.</bold> </sec>
  • The journal of vascular access.J Vasc Access.2014 Jan 27;0(0):0. doi: 10.5301/jva.5000203. [Epub ahead of print]
  • <sec id="st1"><title>ABSTRACT</title> <bold>Arteriovenous hemodialysis fistulas (AVFs) serve as a lifeline for many individuals with end-stage renal failure. A common cause of AVF failure is cephalic arch stenosis. Its high prevalence compounded with its resistance to treatme
  • PMID 24474522
  • Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: initial operative experience.
  • Yao K, Li ZS, Zhou FJ, Qin ZK, Liu ZW, Li YH, Han H.Author information Department of Urology, Cancer Center, Sun Yat-Sen University, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.AbstractTo introduce the technique of anatomical retroperitoneoscopic retroperitoneal lymph node dissection (ARRPLND) was performed in 12 consecutive patients with a clinical stage I nonseminomatous germ-cell tumor (NSGCT) between February 2008 and October 2010. All procedures were performed using a modified template nerve-sparing approach. The retroperitoneal space was adequately expanded using double gasbags. After the retroperitoneal fat was cleared, two relatively bloodless planes were entered consecutively to expose the lymph node and permit dissection. Dissection proceeded first in the plane between the anterior renal fascia and posterior peritoneum, and secondly in the avascular plane between the posterior renal fascia and transversalis fascia. The proximal spermatic vein was clipped at the initial stage. En bloc resection of the lymph tissue and fat between the anterior renal fascia and posterior renal fascia were performed. Three patients (25%) had pathologic stage IIA disease and received adjuvant chemotherapy. No recurrence was observed during follow-up ranging from 26 to 58 months. The median operative time was 205 min (range: 165-430 min) and median estimated blood loss was 320 ml (range: 100-1200 ml). There were two intraoperative complications (Clavien grade II) and one open conversion due to perforation of the peritoneum. Postoperative complications (Clavien I) developed in three patients. Normal antegrade ejaculation recovered by 1 month following the operation. Our preliminary results indicate that ARRPLND is technically feasible and associated with satisfactory clinical outcomes for clinical stage I NSGCT. Further studies are necessary to evaluate this technique.
  • Asian journal of andrology.Asian J Androl.2014 Jan-Feb;16(1):136-9. doi: 10.4103/1008-682X.122188.
  • To introduce the technique of anatomical retroperitoneoscopic retroperitoneal lymph node dissection (ARRPLND) was performed in 12 consecutive patients with a clinical stage I nonseminomatous germ-cell tumor (NSGCT) between February 2008 and October 2010. All procedures were performed using a modifie
  • PMID 24369147

和文文献

  • 縦隔気腫,後腹膜気腫,皮下気腫を認めた直腸S状部穿孔の1例
  • 3D-CTが有用であった交叉性異所性融合腎を併存した直腸癌の1例
  • Retzius腔とはどこか?:-正中アプローチTEP (Totally ExtraPeritoneal repair) における進入経路の解剖-

関連リンク

The renal fascia or Gerota's fascia is a layer of connective tissue encapsulating the kidneys and the suprarenal glands. The deeper layers below the renal fascia are, in order, the adipose capsule of the kidney (or "perirenal fat"), the renal capsule ...
renal fascia n. The condensation of the fibroareolar tissue and fat surrounding and ensheathing the kidney. Also called Gerota's capsule. renal fascia, a membranous condensation of extraperitoneal fascia that encloses the perirenal ...

関連画像


押しても画像が表示されない場合はサーバが混雑しています。2週間ほどあけて、再度押下してください。


★リンクテーブル★
リンク元腎筋膜
関連記事fascia」「renal

腎筋膜」

  [★]

renal fascia (KH,Z)
ゲロータ筋膜ジェロタ筋膜Gerota's fascia、Gerota fascia
腎臓腎摘出術


  • 図:KH.174

概念

腎筋膜の前葉と後葉に包まれるもの


fascia」

  [★]


WordNet   license wordnet

「a sheet or band of fibrous connective tissue separating or binding together muscles and organs etc」
facia

PrepTutorEJDIC   license prepejdic

「(髪を束ねる)細ひも / 鼻隠(はなかくし)板(軒先のたる木の木口を隠す板)」

renal」

  [★]

  • adj.
  • 腎臓の、腎性の、腎の
kidneyrenally

PrepTutorEJDIC   license prepejdic

「腎臓の」




★コメント★

[メモ入力エリア]
※コメント5000文字まで
ニックネーム:
コメント:




表示
個人用ツール


  meddic.jp

リンク
連絡